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Abstract
Background:  The subcommissural organ (SCO) is a highly conserved brain gland present
throughout the vertebrate phylum; it secretes glycoproteins into the cerebrospinal fluid (CSF),
where they aggregate to form Reissner's fiber (RF). SCO-spondin is the major constituent protein
of RF. Evidence exists that the SCO also secretes proteins that remain soluble in the CSF. The aims
of the present investigation were: (i) to identify and partially characterize the SCO-secretory
compounds present in the SCO gland itself and in the RF of the Sprague-Dawley rat and non-
hydrocephalic hyh mouse, and in the CSF of rat; (ii) to make a comparative analysis of the proteins
present in these three compartments; (iii) to identify the proteins secreted by the SCO into the
CSF at different developmental periods.
Methods: The proteins of the SCO secreted into the CSF were studied (i) by injecting specific
antibodies into ventricular CSF in vivo; (ii) by immunoblots of SCO, RF and CSF samples, using
specific antibodies against the SCO secretory proteins (AFRU and anti-P15). In addition, the
glycosylated nature of SCO-compounds was analysed by concanavalin A and wheat germ agglutinin
binding. To analyse RF-glycoproteins, RF was extracted from the central canal of juvenile rats and
mice; to investigate the CSF-soluble proteins secreted by the SCO, CSF samples were collected
from the cisterna magna of rats at different stages of development (from E18 to PN30).
Results: Five glycoproteins were identified in the rat SCO with apparent molecular weights of 630,
450, 390, 320 and 200 kDa. With the exception of the 200-kDa compound, all other compounds
present in the rat SCO were also present in the mouse SCO. The 630 and 390 kDa compounds of
the rat SCO have affinity for concanavalin A but not for wheat germ agglutinin, suggesting that they
correspond to precursor forms. Four of the AFRU-immunoreactive compounds present in the
SCO (630, 450, 390, 320 kDa) were absent from the RF and CSF. These may be precursor and/or
partially processed forms. Two other compounds (200, 63 kDa) were present in SCO, RF and CSF
and may be processed forms. The presence of these proteins in both, RF and CSF suggests a steady-
state RF/CSF equilibrium for these compounds. Eight AFRU-immunoreactive bands were
consistently found in CSF samples from rats at E18, E20 and PN1. Only four of these compounds
were detected in the cisternal CSF of PN30 rats. The 200 kDa compound appears to be a key
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compound in rats since it was consistently found in all samples of SCO, RF and embryonic and
juvenile CSF.
Conclusion:  It is concluded that (i) during the late embryonic life, the rat SCO secretes
compounds that remain soluble in the CSF and reach the subarachnoid space; (ii) during postnatal
life, there is a reduction in the number and concentration of CSF-soluble proteins secreted by the
SCO. The molecular structure and functional significance of these proteins remain to be elucidated.
The possibility they are involved in brain development has been discussed.
Background
The subcommissural organ (SCO) differentiates at an
early stage of ontogenetic development in all vertebrates
[1] and, with the exception of a few species (anthropoids
and bats) [2], it remains fully active throughout life. The
secretion of this gland is released into the ventricular cer-
ebrospinal fluid (CSF) where most of it condenses to form
a filamentous structure named after Reissner [3] as Reiss-
ner's fiber (RF). RF is formed by the assembly of complex-
type, high molecular weight glycoproteins secreted by the
SCO into the cerebral aqueduct; it is a dynamic structure
that continuously grows caudally by the addition of newly
released molecules to its cephalic end [2,4]; it extends
throughout the aqueduct of Sylvius, fourth ventricle and
central canal of the spinal cord [4,5]. When arriving at the
terminal ventricle of the central canal at the filum, RF glyc-
oproteins undergo chemical modification, disassembly
and passage into neighbouring vessels [6,7]. RF has the
capacity to bind and transport away compounds such as
dopamine, L-DOPA and serotonin, thus contributing to
the clearance of these compounds from the CSF [8,9].
The identification and characterization of the secretory
compounds of the SCO have been the subject of numer-
ous investigations and have contributed to partial clarifi-
cation of its function. Immunoblot analyses of bovine
SCO using antibodies against RF glycoproteins have led to
the identification of high molecular weight glycoproteins
of 540, 450, 320 and 190 kDa. Evidence has been
obtained indicating that the 540 and the 320 kDa com-
pounds would correspond to precursor forms [10-12]. In
the SCO of chick embryos, del Brio et al. have determined
the presence of three compounds of 540, 320 and 230
kDa [13]. In the SCO of the elasmobranch Scyliorhinus
canicula, five compounds of 600, 475, 400, 145 and 35
kDa have been identified [14]. Antibodies raised against
the precursor form of 540 kDa and the processed form of
450 kDa synthesized by the bovine SCO, when used to
immunostain the bovine and rat SCO, react with the
bovine SCO but not with the rat SCO. At variance, the
antibody against the bovine SCO 320 kDa band reacts
with both, bovine and rat SCO [11,12]. This is the only
information available concerning the secretory com-
pounds of the SCO of murine species.
Ontogenetic studies have revealed that the SCO starts to
express a secretory activity much earlier than the appear-
ance of the first RF [1,15]. In the rat, the SCO is well devel-
oped and immunoreactive with the anti-RF antibodies at
embryonic day 14 (E14). However, aggregated secretory
material and a RF proper first appear during the first post-
natal week [1]. These findings suggest that the embryonic
SCO secretes compounds that remain soluble in the CSF,
thus differing from RF proteins, which aggregate. The
existence of CSF-soluble compounds secreted by the SCO
gained support by immunochemical studies in human
and rabbit CSF [2,16]. Recently, Hoyo-Becerra et al. [17]
have described the presence in the CSF from chick
embryos of proteins that are reactive with anti-RF antise-
rum (AFRU). Efforts to detect SCO glycoproteins in the
bovine CSF have failed [18,19]. None of previous studies
have dealt with the characterization of the SCO secretory
glycoproteins present in the gland itself, in the CSF and in
the RF of the same animal species and using immunoblot
methodology; this has prevented a comparative analysis
of the secretory proteins before they are released and after
they either assemble into RF or remain soluble in the CSF.
Thus, whether the SCO proteins forming RF and the SCO
proteins solubilized in the CSF are the same, or similar or
unrelated compounds has yet to be determined.
The primary structure of the major constituent of bovine
RF, SCO-spondin, has been fully established as a large N-
glycosylated protein (450 kDa) [20,21]. Several lines of
evidence indicate that SCO-spondin plays a role in CNS
development. SCO-spondin belongs to a protein super-
family exhibiting conserved motifs of the thrombospon-
din type 1 repeat [21]. Proteins of this family are strongly
expressed during mammalian CNS development and are
involved in mechanisms of cellular adhesion and axonal
pathfinding [22]. It has not yet been established whether
SCO-spondin itself or its processed products are present
in and circulate through the CSF compartments. Neither
has it been established whether SCO-spondin or related
compounds are actually secreted into the embryonic CSF.
This information is essential when interpreting the poten-
tial role of SCO-spondin in CNS development.
The present investigation was designed to investigate the
rat and mouse SCO glycoproteins in order (i) to identifyCerebrospinal Fluid Research 2008, 5:3 http://www.cerebrospinalfluidresearch.com/content/5/1/3
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and partially characterize the secretory compounds
present in the gland itself, in the RF and in the CSF (rat
only); (ii) to make a comparative analysis of the proteins
present in these three compartments, in order to establish
to what extent they share gel migration, immunoreactive
and lectin-binding properties; and (iii) to identify the pro-
teins secreted by the SCO into the CSF at different devel-
opmental periods. The identification of the CSF-soluble
secretion of the SCO during embryonic and juvenile life
may throw some light on the function of this gland.
Indeed, such CSF-soluble proteins would circulate
throughout both the internal and external CSF compart-
ments and could reach distant targets. Furthermore, differ-
ences in the type or concentration of these CSF-soluble
proteins at different developmental stages may open new
avenues for SCO research.
Methods
Animals
Sprague-Dawley rats and hyh mice: Sprague-Dawley rats
and hyh mice were obtained from The Jackson Laboratory
(Bar Harbor, ME, USA) and bred in two colonies (Fac-
ultad de Medicina, Universidad Austral de Chile, Valdivia,
Chile). Housing, handling, care and processing of animals
were carried out according to the regulations approved by
the council of the American Physiological Society. A local
university committee has approved the experimental pro-
tocol. Animals were fed ad libitum with rodent food and
maintained under a constant 12-h light/dark photoperiod
and at a constant temperature. Female rats were checked
for the presence of a vaginal plug after overnight mating
with a male. At days 18, 19 and 20 of pregnancy, pregnant
rats were weighed and anesthetized with an intraperito-
neal injection of ketamine (40 mg/kg) and acepromazine
(100 mg/kg); embryos were removed and CSF was col-
lected from the cisterna magna.
For mice, the hyh mutation arose spontaneously on the
C57BL/10J. They were then outcrossed onto a B6C3Fe-a/
a background (C57BL/6J × C3HeB/FeJ-a/a). Hence, the
genetic background of hyh  mice strain (B6C3Fe a/a-
Napahyh/J) is C57BL/6J × C3HeB/FeJ-a/a. In the present
study only non-hydrocephalic mice were used. No differ-
ences between wild type and heterozygous mice were
detected with the methods used.
Immunocytochemistry
The brains of 10 Sprague-Dawley rats, PN2, were fixed by
intravascular perfusion with Bouin fixative and embedded
in paraffin. Sections were processed by the immunoperox-
idase method of Sternberger et al. [23]. The following pri-
mary antibodies were used: (i) An antiserum developed in
rabbits against bovine RF-glycoproteins extracted in a
medium containing urea (AFRU, A = antiserum, FR =
Fiber of Reissner, U = urea; [24]), (ii) An antiserum devel-
oped in rabbits against a synthetic 15-aminoacid peptide
with a sequence deduced from a region of the SCO-spon-
din protein that does not correspond to any of the repeats
present in this molecule (anti-P15; [21,25]). This peptide
sequence has no homology with any of the proteins
recorded in the Gene Bank; hence anti-P15 can be
regarded as a specific antibody for SCO-spondin [25]. Sec-
tions were sequentially incubated in: (i) AFRU, dilution
1:1000, or anti-P15, dilution 1:500, for 18 h; (ii) second-
ary antibody (anti-rabbit IgG, raised in our laboratory),
diluted 1:15, for 30 min; (iii) rabbit PAP (Dako, Carpin-
teria, CA, USA), diluted 1:75, for 30 min. All immunocy-
tochemical reactions were visualized by the histochemical
detection of peroxidase using hydrogen peroxide (Merck,
Darmstadt, Germany) and 3-3'diaminobenzidine tetrahy-
drochloride (DAB, Sigma, Madrid, Spain). Omission of
the incubation in the primary antibody was used as a con-
trol.
Injection of antibodies into the rat CSF
Eight PN2 Sprague-Dawley pups were anesthetized with
an intraperitoneal injection of ketamine (40 mg/kg) and
acepromazine (100 mg/kg); anesthesia lasted throughout
the experiment. The head of the pup was immobilized by
placing it into a paraffin cast specially adapted to the head
of PN2 rats. Using a dissecting microscope, a 27-gauge
cannula connected to a perfusion pump, was inserted into
the left lateral ventricle; 3 μl of undiluted AFRU (n = 4) or
anti-P15 (n = 4) sera were infused over 5 min. Two hours
after antibody administration, the brain was dissected out
and fixed by immersion in Bouin's fixative for 2 d. After
dehydration in alcohols, the brains were embedded in
paraffin. For the demonstration of binding sites of the
injected antibodies, sections were sequentially incubated
with anti-rabbit IgG, diluted 1:15, for 30 min, and rabbit
PAP (Dako, Carpinteria, CA, USA), diluted 1:75, for 30
min. This was followed by the diaminobenzidine reac-
tion.
Reissner's fiber extracts
Bovine spinal cord from adult cows was obtained as
described previously [24] and RF was collected by perfus-
ing the central canal of the spinal cord with saline. RF of
10 juvenile rats (PN30) and 8 juvenile mice (PN30) was
collected in the following way: after euthanasia with keta-
mine, the spinal cord was dissected out, immersed in buff-
ered saline and divided into several segments by making
transverse cuts with a razor blade. Under a dissecting
microscope, a cylinder of the grey matter surrounding the
central canal was obtained by doing four longitudinal
cuts; this block of tissue contained the central canal and
the corresponding stretch of RF. The bovine and murine
RFs were extracted in 50 mM ammonium bicarbonate, pH
7,4, containing 0.5 mM phenyl-methylsulfonyl fluoride
(PMSF). The protein concentration of bovine RF extractCerebrospinal Fluid Research 2008, 5:3 http://www.cerebrospinalfluidresearch.com/content/5/1/3
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[26] was 0.8 μg/μl, rat central canal/RF extracts ranged
from 8.0 – 8.6 μg/μl and mouse central canal/RF extracts
ranged from 5.0 – 6.4 μg/μl. Samples were stored at -70°C
until used.
SCO extracts
Fifty PN30 rats and thirty PN30 mice were used. The ani-
mals were sacrificed under ketamine anesthesia, the brain
was dissected out and a block of tissue containing the
SCO and the posterior commissure was obtained under a
dissecting microscope; post-mortem interval was 2–5
min. Six SCOs were pooled to make one sample. Each
sample was extracted in 300 μl of 50 mM ammonium
bicarbonate, pH 7,5, and 0,5 mM phenyl-methylsulfonyl
fluoride (PMSF), homogenized, sonicated in ice for 10 s
and centrifuged at 12.000 g, for 45 min, at 4°C. Three
aliquots of 100 μl, each containing the equivalent of two
SCOs, were obtained from each extracted sample. Protein
content of rat SCO extracts ranged from 1.5 to 2.2 μg/μl
and of mouse SCO extracts from 1.2 – 1.3 μg/μl. Extracts
were stored at -70°C. The bovine SCO of adult animals
was collected and extracted (protein concentration 1.2 –
1.35 μg/μl) as previously reported [12].
Cerebrospinal fluid collection
Rats: E18 (n = 18), E19 (n = 22) and E20 (n = 20) rat
embryos were used for CSF collection. CSF samples were
obtained through a 30-gauge needle inserted into the cis-
terna magna. About 10–15 μl were obtained from each
embryo. Pups at PN1 (n = 12) and PN7 (n = 20) were
anesthetized with ketamine (40 mg/kg) and acepro-
mazine (100 mg/kg), the head flexed and a 27-gauge nee-
dle inserted into the cisterna magna. In PN30 rats (n = 22)
CSF was collected from the cisterna magna according to
Rodríguez et al. [9]. Occasionally, severence of a blood
vessel caused contamination of the samples with blood
and these samples were discarded. About 25–50 μl of CSF
were obtained from each pup and up to 100 μl from each
PN30 rat. CSF samples were collected into Eppendorf
tubes and centrifuged twice to remove cells or cell debris.
Average protein concentrations of E18, E20, PN1, PN7
and PN30 CSF samples were: 2.4, 1.8, 1.5, 1.0 and 0.4 μg/
μl, respectively. Samples were stored at -70°C.
Immunoblot analyses
The following samples were used for blotting: (i) 50 μl
samples of SCO extracts, containing the equivalent of
0.02 bovine SCO, 1 mouse SCO and 1 rat SCO; (ii) 50 μl
samples of RF extracts containing the equivalent of 0.001
bovine RF, 0.1 mouse RF and 0.1 rat RF; (iii) 15 μl of undi-
luted/non concentrated CSF from embryonic and postna-
tal rats. Samples were subjected to SDS-PAGE using a 5–
15% polyacrylamide linear gradient. Proteins were trans-
ferred to nitrocellulose membranes [27]; to block non-
specific binding, blots were saturated with 5% non-fat
milk in 0.1 M PBS containing 0.15 mM NaCl and 0.1%
Tween-20 (Sigma, Madrid, Spain), for 90 min. Two pri-
mary antisera were used for immunoreaction of blots of
SCO and RF: (i) AFRU, 1:25,000 dilution, for 2 h; (ii) anti-
P15 [24], 1:1,000 dilution, for 2 h. Anti-rabbit IgG-HRP
(Pierce, Rockford, IL, USA) was used at 1:25,000 dilution,
for 1.5 h. For immunoblotting of CSF samples, the follow-
ing protocol was used: (i) AFRU, at 1:5,000 dilution and
anti-rabbit IgG-HRP at 1:25,000 dilution, for 2 h; (ii) anti-
P15, at 1:1,000 dilution and anti-rabbit IgG-HRP at
1:60,000 dilution, for 2 h. Incubations were at room tem-
perature and in darkness. Immunoreactive polypeptides
were detected by using an enhanced chemiluminescence
(ECL) system (Super Signal, Pierce, Rockford, IL, USA) as
instructed by the manufacturer. Molecular weight stand-
ards in the range of 10–250 kDa were used (Bio-Rad, Her-
cules, CA, USA). Control blots were processed as above
without the primary antibody. Immunoblotting of sam-
ples was repeated as follows: SCO of rat and mouse × 10;
RF of rat and mouse × 5; rat CSF of E18 and E20 embryos
× 5; rat CSF collected at PN1, PN7 and PN30 × 10. Immu-
noblots were digitized (n = 4 for each condition analysed)
and linear densitograms were obtained using the UN –
SCAN-IT software (Silk Scientific, Orem, UT, USA). Statis-
tical analyses were performed using the Prism software
(GraphPad Software, San Diego, CA, USA) applying the 1-
way Anova and Tukey's test.
Lectin binding
Blots of bovine, rat and mouse SCO in parallel to those
used for immunoblotting, were used to test for lectin
binding. Blots were sequentially incubated with (i) oxi-
dized bovine serum albumin (BSA, Winkler, Santiago,
Chile), (ii) concanavalin A (Con A; affinity = mannose,
glucose; Sigma, St. Louis, MO, USA), 0.2 μg/ml for 1 h;
(iii) anti-Con A developed in rabbits (Sigma, St. Louis,
MO, USA), 1:10,000 dilution for 1 h at room temperature;
(iii) anti-rabbit IgG-HRP (Pierce, Rockford, IL, USA)
1:25,000, for 1.5 h; (iv) binding was detected by using an
enhanced chemiluminescence system (see above). The
same protocol was used for binding of wheat germ agglu-
tinin (WGA; affinity = glucosamine, sialic acid, Sigma, St.
Louis, MO, USA). WGA was used at a concentration of 0.5
μg/ml and anti-WGA (Sigma, St. Louis, MO, USA) was
used at a 1:5,000 dilution.
Con A has affinity for internal, and preferentially for ter-
minal, mannose residues; this makes it a good marker for
newly synthesised glycoproteins that have not yet been
processed through the Golgi apparatus (precursor forms).
At variance, WGA has affinity for two sugar residues (glu-
cosamine, sialic acid) added to the glycoprotein by the
Golgi apparatus, thus being a good marker of post-Golgi
compounds (processed forms) [28,29].Cerebrospinal Fluid Research 2008, 5:3 http://www.cerebrospinalfluidresearch.com/content/5/1/3
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A, C, E: Paraffin sagittal sections through the subcommissural organ (SCO) of a PN2 rat after a single injection of AFRU into a  lateral ventricle (inset 1C, labeled Ab) Figure 1
A, C, E: Paraffin sagittal sections through the subcommissural organ (SCO) of a PN2 rat after a single injection of AFRU into a 
lateral ventricle (inset 1C, labeled Ab). A: Immunostaining using AFRU (raised in rabbits) as primary antibody. The SCO is 
immunoreactive. Arrow points to RF-material. Insert: Detailed magnification of RF fibrils immunoreactive with AFRU (arrows). 
C: Adjacent section to that shown in A, immunostained using anti-rabbit IgG as primary antibody to reveal the antibody 
(AFRU) administered in vivo. The latter appears exclusively bound to the newly released secretory material aggregated on the 
surface of the SCO to form the pre-RF (square) and to aggregated RF-material lying in the ventricle (arrow). E: Detailed mag-
nification of area framed in C showing the location of the antigen-antibody complexes formed in vivo at the pre-RF layer on the 
SCO surface and at the aggregated RF-material. B, D, F: Paraffin sagittal sections through the SCO of a PN2 rat after a single 
injection of anti-P15 into a lateral ventricle. B: Sagittal section through the SCO immunostained with anti-P15. The ependymal 
cells of the SCO appear immunostained (arrow). Lower insert: detailed magnification of the secretory ependyma (E) showing 
the location of the immunoreactive material in the supranuclear cytoplasm. n: nuclei. Upper insert: detailed magnification of RF 
fibrils immunoreactive with anti-P15 (arrows). D: Section immunostained with anti-rabbit IgG as primary antibody to reveal the 
location of the antibody administered in vivo at pre-RF (arrow). F: Detailed magnification of area framed in previous figure 
showing the location of the antigen-antibody complexes formed in vivo at the pre-RF (arrows). IIIV: third ventricle. Most sec-
tions counterstained with hematoxilin.
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Results
Immunocytochemistry
The compounds secreted by rat SCO were identified using
two antibodies. One is directed against bovine RF consti-
tutive proteins (AFRU), whilst anti-P15 is directed against
a 15-aminoacid sequence of SCO-spondin, the main con-
stitutive protein of RF. Both antibodies are highly specific
for the rat SCO secretion, located either intracellularly or
extracellularly in the form of aggregated RF-material (Fig.
1A, B, 2). The SCO-specificity of AFRU and anti-P15 is
also evident when used in vivo. After the intraventricular
administration of these antibodies, they bound exclu-
sively to the SCO secretory material that had been released
into the ventricle and that had aggregated into the form of
pre-RF or RF [4] (Fig. 1C–F, 2A).
Analysis of rat and mouse SCOextracts
The secretory compounds of the SCO of PN30 rats and
mice were analysed in parallel with the well known secre-
tory glycoproteins of the bovine SCO [11,12]. Despite the
small size of the rat and mouse SCO, the use of a high-sen-
sitivity Western blot system based on enhanced chemilu-
minescence enabled demonstration of the secretory
compounds using samples containing the equivalent of
one SCO. As reported previously [12], the Western blot
analysis of the bovine SCO, using AFRU as primary anti-
body, revealed polypeptides of 540, 450, and 320 kDa
(Fig. 2C). The high sensitivity of the method used in the
present study, allowed detection of an additional immu-
noreactive band of 390 kDa (Fig. 2C). The rat and mouse
SCO displayed a pattern of AFRU-immunoreactive bands
that differed from that of the bovine SCO (Fig. 2C). The
540-kDa polypeptide present in the bovine SCO was not
detected in rat and mouse SCO (Fig. 2C). The rat SCO dis-
played AFRU-immunoreactive bands of 630, 450, 390,
320 and 200 kDa (Fig. 2C, Tables 1, 2). In a few blots,
bands of 63 and 45 kDa were also detected (Figs. 2D, 3A,
Tables 2, 3). The compounds of 630 and 200 kDa were
absent from the bovine SCO.
With the exception of the 200-kDa compound, all high
molecular mass compounds present in the rat SCO were
also present in the mouse SCO (Fig. 2C).
Analysis of central canal/Reissner's fiber extracts
Immunoblotting of a tissue extract that included the cen-
tral canal of the spinal cord and RF of mice and rats at
PN30, revealed AFRU-immunoreactive bands most likely
corresponding to RF-glycoproteins. In the rat RF, com-
pounds of 200, 120 and 45 kDa were detected in all blots
(Fig. 2D, Tables 2, 3). Compounds of 63, 50 and 25 kDa
were detected in 2 or 3 of the 5 blots (Tables 2, 3). In the
mouse RF the 200-kDa compound was detected in all
blots; compounds of 63 and 45 kDa were present in most
blots; a polypeptide of 120 kDa was never detected (Fig.
2D).
Analysis of CSF samples
In order to identify those compounds secreted by the SCO
into the CSF and that, at variance with RF-glycoproteins,
remain soluble in the CSF, samples of this fluid were
obtained from embryo, early postnatal and juvenile rats
and analysed by immunoblotting using AFRU and anti-
P15.
CSF samples collected from the cisterna magna during the
late embryonic life (E18, E19, E20) and the early postna-
tal life (PN1, PN7) displayed a very similar pattern of
AFRU-immunoreactive bands (Fig. 2E). The latter were of
200, 180, 164, 145, 120, 63, 50 and 25 kDa (Fig. 2E, Table
2, 3). This band pattern was found in all blots. There were,
however, some differences of intensity of immunoreac-
tion among bands of samples collected at different ages
(E18 to PN7; Fig. 2E, F). The 50 and 25 kDa compounds
were more strongly reactive in fetal CSF, whilst the 200
and 120 kDa polypeptides were more reactive in PN1 and
PN7 samples (Fig. 2E, F).
A marked difference was observed in the cisternal CSF
obtained from PN30 rats; the following bands present in
previous stages were absent: 180, 164, 145 (P < 0.05) and
120 kDa (P < 0.001) and only bands for 200, 63, 50, and
25 kDa were seen (Fig. 2E, F, Table 2, 3).
Comparative analysis of immunoreactive secretory 
proteins in the rat SCO, RF and CSF
The high sensitivity of the Western blot system has ena-
bled for the first time within the same species, detection
of the AFRU-immunoreactive polypeptides present in the
SCO, RF and CSF. This, in turn, has made possible the fol-
lowing comparative analysis: (i) the four AFRU-immuno-
reactive compounds with the largest molecular mass (630,
450,390, 320 kDa) were present in the SCO and missing
from RF and CSF (Table 2, 3). These were possibly precur-
sor or partially processed forms. (ii) Two other com-
pounds (200, 63 kDa) were present in SCO, RF and CSF
(Tables 2, 3), possibly processed forms; (iii) three com-
pounds (200, 120, 63 kDa) were present in RF and CSF
(Table 2) and possibly in a steady-state equilibrium; (iv)
CSF of rat embryos had five bands (180, 164, 145, 50, 25
kDa) not detected in the rat SCO or RF at PN30 (Table 2,
compare Figs. 2D and 2E); (v) CSF of PN30 rats had two
bands (50, 25 kDa) not detected in the rat SCO and
inconsistently detected in RF at PN30 (Table 2). The 200-
kDa compound was consistently found in all blots of
SCO, RF and CSF from rats (Table 2).Cerebrospinal Fluid Research 2008, 5:3 http://www.cerebrospinalfluidresearch.com/content/5/1/3
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A: Schematic representation of a secretory ependymal cell of the rat SCO Figure 2
A: Schematic representation of a secretory ependymal cell of the rat SCO. In the rough endoplasmic reticulum secretory pro-
teins have N-linked, high mannose type oligosaccharides (1). In the Golgi cisternae glucosamine, galactose and sialic acid are 
conjugated to the saccharide core (2). In the secretory granules and in the released secretion, the backbone protein of the 
secretory glycoproteins undergoes cleavage (3, arrow) [12, 28]. The secretory glycoproteins released into the ventricle may 
become densely packed forming Reissner's fiber (RF) or may remains soluble in the cerebrospinal fluid (from Rodriguez et al. 
[16]). B: Schematic representation of a N-linked, complex type, oligosaccharide. The core of glucosamine and mannose are 
conjugated in the rough endoplasmic reticulum (RER); glucosamine, galactose and sialic acid are conjugated in the Golgi appara-
tus (GA). Concanavalin A (Con A) has affinity for internal and terminal mannose residues; wheat germ agglutinin (WGA) has 
affinity for terminal residues of glucosamine and sialic acid. C: Immunoblotting analysis of the subcommissural organ (SCO) 
using AFRU as primary antibody. Four immunoreactive polypeptides are detected in the adult bovine SCO, five in the PN30 rat 
SCO and four in the PN30 mouse SCO. Numbers: refer to molecular weight in kDa; arrows: secretory compounds; asterisk 
indicates the absence of 200 kDa compound. D: Immunoblotting analyses using AFRU as primary antibody of extracts of rat 
SCO and rat and mouse central canal (CC) at PN30. Numbers refer to molecular weight in kDa. Two polypeptides of 200 and 
45 kDa were present in all samples. Asterisk: immunoreactive band of 120 kDa present only in the rat central canal. E: West-
ern blot analysis of cisternal CSF collected from E18, E20, PN1, PN 7 and PN30 rats. Numbers refer to molecular weight in 
kDa. Eight immunoreactive polypeptides are detected in the CSF collected perinatally (E18, E20, PN1, PN7) (horizontal lines). 
Four of these compounds are missing from the CSF of PN30 rats (asterisks). F: Densitometric linear scannings of CSF immuno-
blots at E18, PN1 and PN30. The statistical analysis using four immunoblots each revealed a significant difference in lumines-
cence value of the 120 kDa band between E18 and PN1 (*, P < 0.001), and between PN1 and PN30 (P < 0.001). Differences 
between E18 and PN30 in the 180, 164 and 145 kDa bands were also significant (&#x25CA;, P < 0.05).
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Comparison of immunoblot analysis of SCO, RF and CSF 
using AFRU and anti-P15
Blots of rat SCO run in parallel and immunoreacted with
AFRU and anti-P15 showed: (i) out of the four com-
pounds of large molecular weight revealed by AFRU, only
the 320 kDa reacted with anti-P15 (Fig. 3A, Table 3); (ii)
the bands of 63 and 45 kDa reacted with both antibodies
(Fig. 3A, Table 3); (iii) bands of 80, 37 and 32 kDa only
reacted with anti-P15 (Fig. 3A, Table 3).
Blots of rat RF run in parallel and immunoreacted with
AFRU and anti-P15 showed: (i) both antibodies reacted
with the 200, 120 and 45 kDa compounds (Table 3); (ii)
bands of 320, 164, 145, 80 and 32 kDa only reacted with
anti-P15 (Table 3).
Blots of CSF of E18, E20 and PN7 rats run in parallel and
immunoreacted with AFRU and anti-P15 showed: (i) out
of the eight bands revealed by AFRU (200 to 25 kDa), only
the 200, 180, 145 and 63 kDa reacted with anti-P15 (Fig.
3B, Table 3).
Evidence for the existence of two precursor forms of the 
secretory proteins in the rat and mouse SCO
Proteins extracted from the rat, mouse and bovine SCO
were blotted and run in parallel for immunoreaction with
AFRU and Con A and WGA binding (Fig. 2B, 4; Table 1).
In bovine SCO, four bands that immunoreacted with
AFRU (540, 450, 390 and 320 kDa) bound Con A (Fig.
4A, Table 1). The five polypeptides detected with AFRU in
the rat SCO (630, 450, 390, 320, 200 kDa) bound Con A,
but only the compounds of 450, 320 and 200 kDa bound
WGA (Fig. 4B, Table 1).
The four polypeptides detected with AFRU in the mouse
SCO (630, 450, 390, 320 kDa) were Con A-positive (Fig.
Table 1: Immunoreactivity to AFRU and lectin binding of proteins extracted from the bovine, rat and mouse subcommissural organ
MW *Bovine SCO (adult) Rat SCO (PN30) Mouse SCO (PN30)
AFRU Con A WGA AFRU Con A WGA AFRU Con A WGA
630 ++-++-
540 ++-
450 +++++++++
390 ++ ++-++-
320 ++-++++++
200 +++
MW, molecular weights in kilo Daltons; SCO, subcommissural organ; AFRU, antibody against all glycoproteins of bovine RF; Con A, concanavalin A 
(affinity = mannose, glucose); WGA, wheat germ agglutinin (affinity = glucosamine, sialic acid); +, positive reaction; -, negative reaction. *From 
Nualart et al. 1991 [12].
Table 2: Comparative analysis of AFRU-immunoreactive proteins extracted from the rat subcommissural organ, Reissner's fiber and 
from the cisterna magna CSF
MW SCO (PN30) RF (PN30) CSF (E18-PN7) CSF (PN30)
AFRU ConA WGA AFRU AFRU AFRU
630 ++-
450 +++
390 ++-
320 +++
200 ++++++
180 +
164 +
145 +
120 ++
63 ** + +
50 *++
45 *+
25 *++
MW, molecular weights in kilodaltons; SCO, subcommissural organ; RF, Reissner's fiber; AFRU, antibody against all glycoproteins of bovine RF; Con 
A, concanavalin A (affinity = mannose, glucose); WGA, wheat germ agglutinin (affinity = glucosamine, sialic acid); +, positive reaction consistently 
present in all samples; *, positive reaction only found in some samples. Two upper boxes indicate putative precursor forms only present in SCO. 
Lower box indicates the only compound consistently found in SCO, RF and CSF (processed form).Cerebrospinal Fluid Research 2008, 5:3 http://www.cerebrospinalfluidresearch.com/content/5/1/3
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4C); only the 450 and 320 kDa compounds bound WGA
(Fig. 4C, Table 1).
Discussion
Identification of the precursor and processed forms of the 
glycoproteins secreted by the rat and mouse SCO
Reissner's fiber results from the assembly of large molecu-
lar weight proteins released by the SCO into the CSF cir-
culating through the cerebral aqueduct. The major
constituent protein of RF is SCO-spondin. The aminoacid
sequence of bovine SCO-spondin has been fully estab-
lished by Meiniel [21]. In the bovine SCO, three major
compounds of 540, 450 and 320 kDa, reacting with an
antiserum raised against the constitutive proteins of RF
(AFRU), have been described [12]. Due to the lectin bind-
ing properties and the subcellular localization of these
three compounds, Nualart et al. [25] have selected a 15-
aminoacid sequence from a region of SCO-spondin that
was used to raise antibodies in rabbits. This antibody
(anti-P15) specifically reacts with the bovine and rat SCO
and RF and can be regarded as a specific marker of SCO-
spondin [25]. In immunoblots of bovine SCO, anti-P15
reacts with the 540 and 450 kDa bands, indicating that
both bands correspond to SCO-spondin, with the former
being the precursor and the latter a processed form. The
molecular weight deduced from the aminoacid sequence
of bovine SCO-spondin is 540 kDa [30]. The nature of the
320 kDa protein has yet to be investigated.
In the rat and mouse SCO, the 540 kDa compound was
absent; instead an AFRU-immunoreactive compound of
630 kDa was seen. This compound has immunoreactive
and lectin-binding properties similar to the bovine 540
kDa SCO-spondin, indicating that it corresponds to a
murine SCO-spondin. The sequence of the mouse SCO-
spondin contains 4981 aminoacids with a theoretical pro-
tein mass of 535 kDa. When compared to the bovine
SCO-spondin there is a 66.8% homology [30].
Considering the large number of cryptic sites of N-glyco-
sylaton present in the sequence of SCO-spondin, the
larger molecular mass of rat and mouse SCO-spondin
could be due to a higher degree of glycosylation.
According to the lectin binding properties of all AFRU-
immunoreactive glycoproteins present in the rat and
mouse SCO (Table 1), the 630 and 390 kDa compounds
would correspond to precursor forms present in the rough
endoplasmic reticulum of the SCO secretory cells. Indeed,
they bound Con A, a lectin with affinity for mannose res-
idues added to the nascent protein in the rough endoplas-
mic reticulum, but did not bind WGA, a lectin specific for
two sugar residues (glucosamine, sialic acid) added to the
glycoprotein by the Golgi apparatus [2,4]. At variance, the
450, 320 and 200 kDa proteins did bind WGA, indicating
that they are post-Golgi compounds located, most likely,
in the secretory granules. The presence of the 200 kDa
glycoprotein in RF is strongly supportive of the suggestion
that this compound corresponds to a processed form.
Out of the four compounds of large molecular weight
revealed by AFRU in the rat SCO, only the 320 kDa
reacted with anti-P15 (Table 3). Since this antibody is spe-
cific for SCO-spondin, it may be postulated that the 320
kDa protein corresponds to SCO-spondin. However, anti-
P15 did not reveal the 630 kDa compound that most
likely corresponds to the precursor of the rat SCO-spon-
din. A likely explanation for this result is that anti-P15,
reacting with a 15-aminoacid sequence of a protein that
consists of about 4,500 amino acids, might not have
access to its epitopes when rat SCO-spondin is in its pre-
cursor form.
Out of the eight bands consistently revealed by AFRU in
the embryonic CSF, only four of them (200, 180, 145, 63
kDa) reacted with anti-P15. This suggests that the latter
compounds would be derived from the SCO-spondin pre-
cursor (630 kDa) and the AFRU-positive, anti-P15-nega-
tive compounds derived from the second putative
precursor (390 kDa).
Are CSF-soluble compounds secreted by the SCO 
intracellularly processed and released into CSF, or 
"released" from RF?
The 200 kDa appears as a key protein, since it was present
in the SCO, RF and embryonic and juvenile CSF of rats,
and immunoreacted with AFRU and anti-P15. This
indicates that this protein is a processed form of SCO-
spondin released by the SCO cells into the CSF. In the rat,
the 200 kDa compound represented the major constitu-
ent protein of RF. A steady-state RF/CSF equilibrium for
this protein might explain the permanent presence of this
compound in both, RF and CSF. On the other hand, the
presence of the 200 kDa protein in the embryonic CSF,
before the first RF has formed, and in the juvenile cisternal
CSF, a compartment where RF is absent, indicates that this
protein is secreted as a CSF-soluble protein and remains
soluble in the circulating CSF.
The 63 kDa protein detected in all CSF samples and in
some samples of SCO and RF, might also be regarded as a
processed form secreted by the SCO to form RF as well as
to be CSF-soluble.
The two proteins of 180 and 164 kDa, found in the
embryonic CSF but absent from the juvenile SCO, CSF
and RF, would correspond to processed forms released by
the SCO during late embryonic life. Since immunoblot
analysis of the embryonic SCO has not been performed,
the possibility that these compounds were derived from aCerebrospinal Fluid Research 2008, 5:3 http://www.cerebrospinalfluidresearch.com/content/5/1/3
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source other than the SCO has to be considered. Indeed,
from E15 to PN1 the rat floor plate, that extends along the
ventral midline of the spinal cord and hindbrain, secretes
proteins immunoreactive with AFRU [31]. Although floor
plate explants release these proteins to culture medium
[32], there is no evidence that they are actually released
into the embryonic CSF.
There were AFRU and anti-P15 immunoreactive proteins
present in the rat RF and/or juvenile CSF (120, 50, 25
kDa) that were absent from the SCO. Since these com-
pounds were consistently detected in all blots, it seems
unlikely they result from artefactual degradation of larger
proteins during handling and processing of the samples.
The possibility that these proteins result from a post-
release cleavage of compounds secreted by the SCO into
the CSF has to be considered and investigated. A similar
phenomenon has been described in bovines, where sev-
eral AFRU-immunoreactive polypeptides forming RF are
not present in the SCO [11,12,33]. The possibility of a
post-release processing of high molecular mass glycopro-
teins released into the CSF of chick embryos has been
suggested [17]. In the bovine, the wall of the central
canal, especially at the lumbo-sacral level, contains
AFRU-reactive cells [34]. These cells have not been
detected in the rat and mouse central canal. However,
considering that in the present investigation, rat RF was
extracted together with the wall of the central canal, the
possibility should be considered that AFRU-immunore-
active proteins present in the central canal/RF extract but
absent in the SCO extract, may have originated from cells
lining the central canal.
The CSF-soluble compounds secreted by the rat SCO 
circulate in the internal and external CSF compartments
After the intraventricular injection of an antibody against
RF-proteins, such an antibody immunoreacts with the
proteins newly released by the SCO, forming insoluble
antigen-antibody complexes on the surface of this gland
that were detected by immunocytochemistry using anti-
IgG as primary antibody [35]. The same procedure has
been used in the present investigation. AFRU and anti-P15
injected into the ventricular CSF formed insoluble anti-
gen-antibody complexes exclusively located on the surface
of the SCO, indicating that the rat SCO does secrete AFRU
and anti-P15 reactive compounds into the third ventricle.
Since AFRU and anti-P15 reactive compounds are also
present in the cisternal CSF (see above), it may be con-
cluded that the CSF-soluble proteins secreted by the SCO
into the third ventricle circulate through the aqueduct of
Sylvius, fourth ventricle and subarachnoid space.
In the fetal CSF the number and concentration of SCO 
secretory products is higher than in the CSF of juvenile rats
The developing CNS of various vertebrate species has
been investigated using methods to visualize RF-proteins.
Two structures, the floor plate and the SCO, have been
shown to share the property to synthesize RF-like material
[36,37]. The use of anti-RF sera has confirmed that both
structures secrete proteins reacting with these antibodies
[31,37,38]. It has also been shown that both, the floor
Table 3: Immunoreactivity to AFRU and anti-P15 of proteins extracted from the rat subcommissural organ, Riessner's fiber and 
cisterna magna CSF
MW SCO (PN30) RF (PN30) CSF (E18-PN7)
AFRU Anti-P15 AFRU Anti-P15 AFRU Anti-P15
630 +
450 +
390 +
320 ++ +
200 + ++++
180 ++
164 ++
145 +++
120 +++
80 ++
63 ****+*
50 ** +
45 **++
37 +
32 ++
25 *+
MW, molecular weights in kilodaltons; SCO, subcommissural organ; RF, Reissner's fiber; AFRU, antibody against all glycoproteins of bovine RF; anti-
P15, antibody specific for SCO-spondin; +, positive reaction consistently present in all samples; *, positive reaction only found in some samples. 
Horizontal box indicates 200 kDa compound consistently found in all samples. The eight AFRU-immunoreactive compounds detected in embryonic 
CSF were consistently found in all samples; only three of them react with anti-P15.Cerebrospinal Fluid Research 2008, 5:3 http://www.cerebrospinalfluidresearch.com/content/5/1/3
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plate and SCO of bovine embryos, express the SCO-spon-
din gene and synthesize the 540 kDa protein [39]. The rat
floor plate synthesizes AFRU-immunoreactive proteins
from E15 to PN1, with the highest activity around E18
[31]. In vitro studies have shown that the bovine floor
plate cells release AFRU-reactive proteins of 540 and 60
kDa into the culture medium [32]. The rat SCO starts to
secrete AFRU-reactive material at E14; by E18 it is fully
developed and displaying a high secretory activity [1].
Since RF starts to form at PN1, and a RF proper is first seen
in the central canal at PN7, it has been assumed that the
compounds secreted by the fetal SCO remain soluble in
the CSF [1].
In the present investigation, eight AFRU-immunoreactive
compounds were consistently found in all CSF samples
collected from E18 to PN1. Only four of these compounds
(200, 63, 50, 25 kDa) were also detected in the CSF of
juvenile rats. It may be assumed that the source of these
proteins is the SCO since in the juvenile rat this gland is
the only brain structure secreting AFRU-reactive proteins.
On the other hand, the four AFRU-immunoreactive pro-
teins present only in the CSF collected from E18 to PN1
could be secreted by the SCO, the floor plate or by both
glands. Five AFRU-immunoreactive proteins have been
shown to occur in the CSF of chick embryos [17]. The
authors obtained evidence to suggest that in chick
embryos, these proteins may be derived from both the
SCO and floor plate.
Functional significance of the existence of CSF-soluble 
proteins secreted by the SCO
The embryonic CSF may be regarded as the main compo-
nent of the milieu of stem cells and progenitor cells of the
germinal zone [40]. In rat embryos, the flowing CSF is in
permanent and direct contact with the ventricular and
subventricular zones and, after E17, it reaches the sub-
arachnoid space to bathe the marginal zone of the brain
cortex [41]. The CSF is an efficient route to convey signals
between different regions of the brain [41,42]. In the adult
rat, tracers injected into the ventricles move freely into the
brain parenchyma through the ependymal lining [43-45];
similarly, tracers injected into the subarachnoid space
enter the brain parenchyma through the pial surface
[44,46-48]. However, the functional relationship between
the ventricular and subrachnoid compartments and the
parenchyma of the embryonic brain is not clear. There is
a significant body of evidence indicating that CSF carries
vital signal molecules to the germinal epithelium of the
developing brain cortex [41,49,50]. CSF from rat
embryos, used as culture medium, has the capacity to sus-
tain the proliferative activity of the embryonic cerebral
cortex [51]. Rat CSF collected at E19 has the highest capac-
ity to induce neuronal proliferation, compared to CSF
obtained at other developmental periods, indicating that
the CSF composition changes during development [51].
Rat CSF promotes the neuronal differentiation from neu-
rospheres obtained from stem cells of the subventricular
zone of the lateral ventricle [52]. Several factors known to
participate in brain development have been detected in
the embryonic CSF, namely, fibroblast growth factor
(FGF2), epidermal growth factor (EGF), transforming
growth factor TGF-b), neural growth factor (NGF), brain-
derived growth factor (BDGF), transthyretin [53-62]. The
source of most of these signals in not known.
The eight AFRU-immunoreactive compounds detected in
the CSF of rat embryos (present report), especially those
that also react with anti-P15 (a SCO-spondin marker), are
good candidates to participate in brain development. This
possibility is supported by previous observations. The
immunological blockage of the SCO during development
by maternal transfer of antibodies leads to brain abnor-
malities [63]. There is strong evidence indicating that
SCO-spondin promotes neuronal growth and differentia-
tion [64]. The fact that the eight AFRU-immunoreactive
compounds have been detected in the cisterna magna CSF
Immunoblots of rat SCO at PN30 (panel A) and cisternal CSF  at PN7 (panel B), using AFRU and anti-P15 as primary anti- bodies Figure 3
Immunoblots of rat SCO at PN30 (panel A) and cisternal CSF 
at PN7 (panel B), using AFRU and anti-P15 as primary anti-
bodies. The four AFRU-immunoreactive compounds with the 
largest molecular mass (630, 450,390, 320 kDa) are present 
in the SCO and missing from the CSF. Two other com-
pounds (200, 63 kDa) are present in the SCO and CSF (proc-
essed forms?). The CSF has four bands (180, 164, 145, 120 
kDa) not seen in the SCO. The SCO has only one large 
molecular mass compound reacting with anti-P15 (specific 
for SCO-spondin) and several bands of lower molecular 
masses. The CSF compounds of 200, 180, 145 and 63 kDa, 
reacting with both antibodies are most likely to be SCO-
spondin derivatives.
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indicates they follow the flow of the subarachnoidal CSF
and may gain access to the marginal zone of the develop-
ing brain cortex. Worth mentioning is the fact that F-spon-
din, secreted by the floor plate, SCO-spondin secreted by
the SCO and reelin, secreted by the Cajal-Retzius cells of
the developing cortex, display regions of similarities in
their aminoacid sequences and all of them are glycopro-
teins secreted into the extracellular space [21,65].
The four AFRU-immunoreactive compounds that con-
tinue to be present in the CSF of juvenile rats may also be
involved in neurogenesis, specially that occurring in the
subventricular zone of the lateral ventricle. Transplanta-
tion of SCO explants to a lateral ventricle of juvenile rats
stimulates neuroblast proliferation and migration [66].
Conclusion
The present investigation has shown that (i) during late
embryonic life, the SCO secretes compounds that remain
soluble in the CSF and reach the subarachnoid space; (ii)
during postnatal life, there is a reduction in the number
and concentration of CSF-soluble proteins secreted by the
SCO. The molecular structure and functional significance
of these proteins remain to be elucidated. A glycoprotein
of 200 kDa, found in all rat samples, may be a key com-
pound for SCO function.
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